Wide resection and limb-salvage surgery remain the gold standard for the management of patients with soft tissue sarcomas of the extremities. Innovations in understanding tumor biology and limb-salvage techniques have led amputation rates to decline. Radiation therapy and novel chemotherapy agents and dosing regimens are supplementing oncology-related surgical treatment. A multidisciplinary team approach with input from oncologists, pathologists, radiation oncologists, and orthopaedic and plastic surgeons is necessary for the management of patients with soft tissue sarcomas of the extremities.





Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
75% Article relates to my practice (3/4)
25% Article does not relate to my practice (1/4)
0% Undecided (0/4)
2

Will this article lead to more cost-effective healthcare?

50% Yes (2/4)
50% No (2/4)
0% Undecided (0/4)
3

Was this article biased? (commercial or personal)

0% Yes (0/4)
100% No (4/4)
0% Undecided (0/4)
4

What level of evidence do you think this article is?

25% Level 1 (1/4)
0% Level 2 (0/4)
75% Level 3 (3/4)
0% Level 4 (0/4)
0% Level 5 (0/4)